Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1993
12/23/1993CA2137367A1 Peptides having platelet-derived growth factor (pdgf) activity
12/23/1993CA2114420A1 Use of growth factor igf-ii
12/22/1993EP0575210A1 Azole derivatives, pharmaceutical compositions containing the same, and methods for treating mycosis and estrogen-dependent diseases
12/22/1993EP0575097A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS
12/22/1993EP0574846A2 Imidazopyridines as angiotensin II antagonistes
12/22/1993EP0574787A2 Benzimidazole derivatives as angiotensin II antagonists
12/22/1993EP0574758A1 Hydroxamic acid derivatives as collagenase inhibitors
12/22/1993EP0574579A1 Dna encoding a human 5-ht 1f? receptor and uses thereof
12/22/1993EP0574457A1 Antiviral nucleoside combination
12/22/1993EP0574424A1 Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
12/22/1993EP0574391A1 Antibodies against the urokinase receptor and their use
12/22/1993EP0413016B1 Novel compositions containing hyaluronic acid associates and a process for preparing same
12/22/1993CN1079747A Steroid 5-alpha-reductase inhibitors
12/22/1993CN1079732A Pharmaceutical compounds
12/22/1993CN1079651A Minimizing progestin associated breakthrough bleeding
12/22/1993CN1079649A Imidazolyl-alkenoic acids
12/22/1993CN1079648A Imidazolyl-alkenoic acids
12/21/1993US5272154 3,7 substituted indole and indazole compounds and pharmaceutical compositions containing them
12/21/1993US5272143 6-oxoazepinoindole compounds, and pharmaceutical compositions containing them
12/21/1993US5272064 DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
12/21/1993CA1325431C Di-t-butylphenols substituted by an alkoxy or benzyloxy group or a benzylthio group
12/21/1993CA1325422C Prodrug derivatives of carboxylic acid drugs
12/20/1993CA2098165A1 Inhibitors of hiv protease useful for the treatment of aids
12/18/1993CA2098473A1 Imidazopyridines
12/15/1993EP0574313A1 1,4-Disubstituted piperazines for the treatment of disorders of the central nervous system and neuro-endocrine disorders
12/15/1993EP0574256A1 Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
12/15/1993EP0574174A2 Angiotensin II antagonists
12/15/1993EP0573568A1 Use of nicotinic analogs for treatment of degenerative diseases of the nervous system
12/15/1993EP0573565A1 Opiate receptor antagonist modulates hyperkinetic movement disorder
12/15/1993EP0573498A1 Aliphatic propargylamines as selective mao-b inhibitors and as neuroprotective agents
12/15/1993EP0349569B1 BOVINE INTERLEUKIN-1$g(b)
12/15/1993CN1079469A New compounds
12/15/1993CN1079464A New compounds
12/14/1993US5270342 Acetamide derivatives
12/14/1993US5270331 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
12/14/1993US5270330 2-nitroimidazole derivative, production thereof, and radiosensitizer containing the same as active ingredient
12/14/1993US5270324 Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
12/14/1993US5270322 Imidazo[1,2-a]pyridines, pharmaceutical compositions containing these compounds and processes for preparing them
12/14/1993US5270312 Substituted piperazines as central nervous system agents
12/14/1993US5270311 [1,2,4]-Triazolo[1,5-a]and pyrazolo[2,3-a][1,3,5]triazine derivatives
12/14/1993US5270301 Fluoro-amide derivatives
12/14/1993US5270300 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
12/14/1993CA2098243A1 Benzimidazole derivatives
12/14/1993CA1325210C Phenolethanolamines, their use as pharmaceuticals and as growth enhancers for animals and processes for their preparation
12/13/1993CA2098252A1 1,4-di-substituted piperazines, process for preparing them et pharmaceutical compositions containing them
12/12/1993CA2098168A1 Hydroxamic acid derivatives
12/09/1993WO1993024650A1 Therapeutic compositions
12/09/1993WO1993024643A1 Farnesyltransferase inhibitors oh-4652 and production thereof
12/09/1993WO1993024529A1 Retinal pigmented epithelium derived neurotrophic factor
12/09/1993WO1993024525A1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
12/09/1993WO1993024524A1 Single chain peptide compounds having hemoregulatory activity
12/09/1993WO1993024523A1 Double chain peptide compounds having hemoregulatory activity
12/09/1993WO1993024522A1 Double chain peptide compounds having hemoregulatory activity
12/09/1993WO1993024521A1 Bpc peptides, their preparation and use
12/09/1993WO1993024509A1 Erythromycin derivative
12/09/1993WO1993024500A1 Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024499A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024498A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque
12/09/1993WO1993024497A1 Thio-substituted cyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024496A1 Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024495A1 Phosphonosulfonate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024494A1 Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024491A1 Indolocarbazole imides and their use
12/09/1993WO1993024475A1 Sulphamide derivatives as metalloproteinase inhibitors
12/09/1993WO1993024473A1 7-(2-aminoethyl)-benzothiazolones
12/09/1993WO1993024462A1 Substituted-hexahydrobenzo[a]phenanthridines
12/09/1993WO1993024449A1 Peptidyl derivatives and their use as metalloproteinases inhibitors
12/09/1993WO1993024448A1 Amino acid derivative and use thereof
12/09/1993WO1993024144A1 PREPARATION FOR ACTIVATION OF NATURAL KILLER CELLS (NK-CELLS), SAID PREPARATION CONTAINING INTERFERON-α AND HISTAMINE, SEROTONIN OR SUBSTANCES WITH CORRESPONDING RECEPTOR ACTIVITY
12/09/1993WO1993024142A1 New pharmaceutical uses of krill enzymes
12/09/1993WO1993024134A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1
12/09/1993WO1993024131A1 Phosponocarboxylate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024126A1 Substituted arginines and substituted homoarginines and use thereof
12/09/1993CA2306952A1 Method for removing dental plaque
12/09/1993CA2136819A1 Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism
12/09/1993CA2136624A1 Peptides of human p53 protein for use in human t cell response inducing compositions, and human p53 protein-specific cytotoxic t-lymphocytes
12/09/1993CA2136349A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1
12/09/1993CA2114623A1 Sulphamide derivatives as metalloproteinase inhibitors
12/09/1993CA2114622A1 Peptidyl derivatives and their use as metalloproteinases inhibitors
12/08/1993EP0573392A1 Thiosemicarbazones derivatives and their use as pharmaceuticals
12/08/1993EP0573271A1 Angiotensin II antagonists
12/08/1993EP0573253A2 Topical anti-bacterial composition
12/08/1993EP0573221A1 The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy
12/08/1993EP0573218A2 4-Carboxyimidazoles as angiotensin II antagonists and their thrapeutic use
12/08/1993EP0573133A1 Means for transdermal application of Gestoden
12/08/1993EP0572909A1 Amino acid derivatives as renin inhibitors
12/08/1993EP0572688A1 Peptides with organo-protective activity, the process for preparing them and their use in therapy
12/08/1993EP0572573A1 Thyroid-derived chondrocyte-stimulating factor
12/08/1993EP0572560A1 Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology
12/08/1993EP0572553A1 Recombinant thrombin receptor and related pharmaceuticals
12/08/1993EP0572537A1 Cytokine inhibitors
12/08/1993EP0572505A1 Human platelet-derived growth factor receptors
12/08/1993EP0572455A1 Substituted pyridinones and pyrimidinones as angiotensin ii antagonists
12/08/1993EP0409858B1 Heparin-binding proteins, dna coding for them, processes for producing them as well as therapeutic preparations containing them
12/08/1993CN1079219A Arylacetamides
12/08/1993CN1023014C Process for preparing ergoline derivatives
12/07/1993US5268387 Containing ester or carbamate group
12/07/1993US5268386 Certain 3,4-dihydro 4-oxospiro [2H-1 benzopyrans] useful for treating hyperuricemia
12/07/1993US5268377 Imidazoindolizine derivatives process for preparation thereof and use thereof to treat hypertension
12/07/1993US5268375 Dinitrogen heterocyclic derivatives N-substituted by a biphenylmethyl group, and the pharmaceutical compositions in which they are present
1 ... 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 ... 1564